SPI-62: Clinical Trials

5 trials of SPI-62, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Recruiting 1
Phase 12Completed 1, Terminated 1

Follow SPI-62: new trials by email Literature Review of SPI-62 trials Research Report on SPI-62

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
clofutriben, Placebo - Type 2 Diabetes, Cortisol Excess
Phase 2RecruitingSparrow Pharmaceuticals15002025-11-292026-10-06
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
SPI-62, Placebo - Cushing's Syndrome I, Cushing Disease Due to Increased ACTH Secretion
Phase 2CompletedSparrow Pharmaceuticals262022-09-012025-10-08
A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)
SPI-62, SPI-62 matched placebo, Prednisolone 10mg - Polymyalgia Rheumatica
Phase 2CompletedSparrow Pharmaceuticals662022-07-222025-05-11
A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)
Prednisolone, SPI-62 - Polymyalgia Rheumatica
Phase 1TerminatedSparrow Pharmaceuticals12022-02-222025-05-16
A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62
SPI-62, Cortisone-d8 - Type 2 Diabetes Mellitus in Obese, Obesity
Phase 1CompletedSparrow Pharmaceuticals122021-07-232024-04-22

Conditions studied

ACTH Syndrome, Ectopic (2)  ·  Cushing Syndrome (2)  ·  Polymyalgia Rheumatica (2)  ·  Diabetes Mellitus, Type 2 (1)  ·  Obesity (1)  ·  Pituitary ACTH Hypersecretion (1)

Sponsors

Sparrow Pharmaceuticals (5)

Countries

United States (3)  ·  Germany (2)  ·  Bulgaria (1)  ·  Poland (1)  ·  Romania (1)

Top investigators

David Katz (2)  ·  David Katz, PhD (1)  ·  Frank Czerwiec, MD (1)

Results publications

PMID 41240060